Replies to post #21 on Altamira Therapeutics Ltd (CYTO)

[exisnet]

CYTO... more I read more I like. Interesting presentation and Q&A session with Michael Becker - President and CEO and Kevin Bratton, Chief Financial Officer:

http://seekingalpha.com/article/47821-cytogen-the-wall-street-analyst-forum-presentation-transcript?....

Partial Quote:

"In terms of the market opportunity for CAPHOSOL, we believe that the market opportunity is approximately $250 million. If you look at the estimated new cases of cancer every year, the percentage that undergo chemotherapy, the number of treatment cycles, the fact that there will be four to ten doses per day and the fact that approximately 40% of all patients will develop oral mucositis. So, this comes up with a market potential of about $250 million and that’s based upon using most of the factors on the left end of the range here, if you use the right end, I think the potential market opportunity could be significantly greater."